Recruiting
Phase 2

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT05535166

Conditions

Medulloblastoma

Eligibility Criteria

Sex: All

Age: 0 - 59

Healthy Volunteers: Not accepted

Interventions

Surgical resection

Ommaya/VPS

Methotrexate

Cisplatin

Vincristine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information